Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo3-(2(S)-azetidinylmethoxy)pyridine:: A radioligand for nicotinic acetylcholine receptors

被引:44
作者
Horti, AG
Koren, AO
Lee, KS
Mukhin, AG
Vaupel, DB
Kimes, AS
Stratton, M
London, ED
机构
[1] NIDA, Brain Imaging Ctr, Intramural Res Program, Baltimore, MD 21224 USA
[2] NIMH, Clin Brain Disorders Branch, Washington, DC 20032 USA
关键词
radiotracer; A-85380; I-123; I-125; radioiodination; nicotinic receptors; acetylcholine; receptor binding; SPECT;
D O I
10.1016/S0969-8051(98)00086-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The radiochemical syntheses of 5-[I-125]iodo-3-(2 (S)-azetidinylmethoxy)pyridine (5-[I-125]iodo-A-85380, [I-125]1) and 5-[I-123]-iodo-A-85380, [I-123]1, were accomplished by radioiodination of 5-trimethylstannyl-3-( (1-tert-butoxycarbonyl-2 (S)-azetidinyl)methoxy)pyridine, 2, followed by acidic deprotection. Average radiochemical yields of [I-125]1 and [I-123]1 were 40-55%; and the average specific radioactivities were 1,700 and 7,000 mCi/mu mol, respectively. Binding affinities of [I-125]1 and [I-123]1 in vitro (rat brain membranes) were each characterized by a K-d value of 11 pM. Preliminary in vivo assay and ex vivo autoradiography of mouse brain indicated that [I-125]1 selectively labels nicotinic acetylcholine receptors (nAChRs) with very high affinity and specificity. These studies suggest that [I-123]1 may be useful as a radioligand for single photon emission computed tomography (SPECT) imaging of nAChRs. NUCL MED BIOL 26;2:175-182, 1999. Published by Elsevier Science Inc.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 44 条
[1]   Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors [J].
Abreo, MA ;
Lin, NH ;
Garvey, DS ;
Gunn, DE ;
Hettinger, AM ;
Wasicak, JT ;
Pavlik, PA ;
Martin, YC ;
DonnellyRoberts, DL ;
Anderson, DJ ;
Sullivan, JP ;
Williams, M ;
Americ, SP ;
Holladay, MW .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) :817-825
[2]   Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors [J].
Bannon, AW ;
Decker, MW ;
Holladay, MW ;
Curzon, P ;
Donnelly-Roberts, D ;
Puttfarcken, PS ;
Bitner, RS ;
Diaz, A ;
Dickenson, AH ;
Porsolt, RD ;
Williams, M ;
Arneric, SP .
SCIENCE, 1998, 279 (5347) :77-81
[3]   INVIVO SPECIFIC BINDING OF [H-3] 1-NICOTINE IN THE MOUSE-BRAIN [J].
BROUSSOLLE, EP ;
WONG, DF ;
FANELLI, RJ ;
LONDON, ED .
LIFE SCIENCES, 1989, 44 (16) :1123-1132
[4]   ACETYLCHOLINE-RECEPTOR - AN ALLOSTERIC PROTEIN [J].
CHANGEUX, JP ;
DEVILLERSTHIERY, A ;
CHEMOUILLI, P .
SCIENCE, 1984, 225 (4668) :1335-1345
[5]  
CLARKE PBS, 1985, J NEUROSCI, V5, P1307
[6]  
DavilaGarcia MI, 1997, J PHARMACOL EXP THER, V282, P445
[7]   DIVERSITY OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS - LESSONS FROM BEHAVIOR AND IMPLICATIONS FOR CNS THERAPEUTICS [J].
DECKER, MW ;
BRIONI, JD ;
BANNON, AW ;
ARNERIC, SP .
LIFE SCIENCES, 1995, 56 (08) :545-570
[8]  
Ding YS, 1996, SYNAPSE, V24, P403
[9]   IN-VIVO LABELING OF NICOTINIC CHOLINERGIC RECEPTORS IN BRAIN WITH [H-3] CYTISINE [J].
FLESHER, JE ;
SCHEFFEL, U ;
LONDON, ED ;
FROST, JJ .
LIFE SCIENCES, 1994, 54 (24) :1883-1890
[10]   BEHAVIORAL AND NEUROCHEMICAL EFFECTS FOLLOWING NEUROTOXIC LESIONS OF A MAJOR CHOLINERGIC INPUT TO THE CEREBRAL-CORTEX IN THE RAT [J].
FLICKER, C ;
DEAN, RL ;
WATKINS, DL ;
FISHER, SK ;
BARTUS, RT .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 18 (06) :973-981